COSM PE Ratio & Valuation, Is COSM Overvalued

Historical Valuation

Cosmos Health Inc (COSM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.26 is considered Undervalued compared with the five-year average of 8.13. The fair price of Cosmos Health Inc (COSM) is between 2.00 to 2.26 according to relative valuation method. Compared to the current price of 0.36 USD , Cosmos Health Inc By Undervalued By 81.91%.

Relative Value

Fair Zone

2.00-2.26

Current Price：0.36

81.91%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Cosmos Health Inc (COSM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Cosmos Health Inc (COSM) has a current Price-to-Book (P/B) ratio of 0.71. Compared to its 3-year average P/B ratio of 0.57, the current P/B ratio is approximately 25.18% higher. Relative to its 5-year average P/B ratio of 10.60, the current P/B ratio is about -93.30% higher. Cosmos Health Inc (COSM) has a Forward Free Cash Flow (FCF) yield of approximately -43.40%. Compared to its 3-year average FCF yield of -80.47%, the current FCF yield is approximately -46.06% lower. Relative to its 5-year average FCF yield of -62.77%, the current FCF yield is about -30.85% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for COSM competitors is 5.75, providing a benchmark for relative valuation. Cosmos Health Inc Corp (COSM.O) exhibits a P/S ratio of 0.26, which is -95.43% above the industry average. Given its robust revenue growth of 37.86%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of COSM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of COSM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is COSM currently overvalued or undervalued?

What is Cosmos Health Inc (COSM) fair value?

COSM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cosmos Health Inc (COSM) is between 2.00 to 2.26 according to relative valuation method.

How does COSM's valuation metrics compare to the industry average?

The average P/S ratio for COSM's competitors is 5.75, providing a benchmark for relative valuation. Cosmos Health Inc Corp (COSM) exhibits a P/S ratio of 0.26, which is -95.43% above the industry average. Given its robust revenue growth of 37.86%, this premium appears sustainable.

What is the current P/B ratio for Cosmos Health Inc (COSM) as of Mar 11 2026?

As of Mar 11 2026, Cosmos Health Inc (COSM) has a P/B ratio of 0.71. This indicates that the market values COSM at 0.71 times its book value.

What is the current FCF Yield for Cosmos Health Inc (COSM) as of Mar 11 2026?

As of Mar 11 2026, Cosmos Health Inc (COSM) has a FCF Yield of -43.40%. This means that for every dollar of Cosmos Health Inc's market capitalization, the company generates -43.40 cents in free cash flow.

What is the current Forward P/E ratio for Cosmos Health Inc (COSM) as of Mar 11 2026?

As of Mar 11 2026, Cosmos Health Inc (COSM) has a Forward P/E ratio of 51.50. This means the market is willing to pay $51.50 for every dollar of Cosmos Health Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cosmos Health Inc (COSM) as of Mar 11 2026?

As of Mar 11 2026, Cosmos Health Inc (COSM) has a Forward P/S ratio of 0.26. This means the market is valuing COSM at $0.26 for every dollar of expected revenue over the next 12 months.

COSM Valuation